Clinical Focus

Previous Articles     Next Articles

Clinical characteristics and risk factors of pulmonary infection in patients with rheumatoid arthritis

  

  1. a.Department of Rheumatology and Immunology; b.Department of Endocrinology and Metabolism;
    c. Department of Nephrology,  the Third Affiliated Hospital of Soochow University, Changzhou 213000, China
  • Online:2020-01-20 Published:2020-03-18
  • Contact: Corresponding author: Wu Min, Email: wuumin@163.com
  • Supported by:
    苏现代医院管理研究----自身免疫病合并感染风险管理评分系统的构建和临床应用(JSY-3-2019-107);江苏现代医院管理研究----三级公立医院在医联体感染管理中的机制研究(JSY-3-2019-098);江苏省高层次卫生人才“六个一工程”拔尖人才科研项目----羟氯喹调控瘦素治疗原发性干燥综合征的疗效及机制研究(LGY2019023);常州市科技计划资助----瘦素调节肠道菌群在胃癌中的作用机制研究(CJ20190103);常州市卫生计生委重大科技项目----瘦素调节肠道菌群在原发性干燥综合征的作用机制及临床应用研究(ZD201707);江苏省博士后科研资助计划----瘦素调节滤泡辅助性T细胞在原发性干燥综合征发病中的作用及机制研究(2019K260);江苏省妇幼健康科研项目----免疫相关性不良妊娠风险管理评分系统的构建及临床应用(F201837);常州市卫计委重大科技项目----常州地区痛风患者的规范化诊疗和精准医疗模式研究(ZD201607)

Abstract:

Objective  To investigate the clinical features and risk factors of pulmonary infection in patients with rheumatoid arthritis (RA). Methods  The clinical data of 52 RA  patients with pulmonary infection and 200 RA patients without  pulmonary infectionwere retrospectively reviewed. Among them,  21 patients were severely infected. The clinical features and risk factors of RA complicated with pulmonary infection and severe pulmonary infection were analyzed. Results  There were 52 cases of pulmonary infection in RA patients,  the positive rate of sputum culture was 36.54%. Totally 25 strains of pathogens were detected,  including 10 strains of bacteria,  3 strains of mycoplasma and 12 strains of fungi. The analysis of related  factors of  pulmonary infection indicated that the independent risk factors included age(>60 years),  RA duration of(≥10 years),  smoking,  chronic lung disease, use of corticosteroids and the decrease of complement C4,  while the use of DMARDs was a protective factor. The analysis of related factors of severe pulmonary infection indicated thatindependent risk factors included RA  duration(≥10 years),  smoking,  chronic lung disease, use of corticosteroids,  and decrease of complement C4,  while the use of DMARDs was a protective factor. Conclusion  The pathogens of pulmonary infection in RA patients were mainly fungi and bacteria. Risk factors for pulmonary infection should be considered when deciding treatment for RA patient. The use of DMARDs can reduce the risk of pulmonary infection in RA patients.

Key words: arthritis, , rheumatoid, pulmonary infection, risk factors